Recent advances in the discovery and development of anti-influenza drugs
- 1 August 2004
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 14 (8), 1153-1168
- https://doi.org/10.1517/13543776.14.8.1153
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidaseBioorganic & Medicinal Chemistry Letters, 2004
- MEK inhibition impairs influenza B virus propagation without emergence of resistant variantsFEBS Letters, 2004
- CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)Seminars in Oncology, 2003
- Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and OseltamivirAntimicrobial Agents and Chemotherapy, 2003
- Quantitative Analysis of Influenza Virus RNP Interaction with RNA Cap Structures and Comparison to Human Cap Binding Protein eIF4EBiochemistry, 2003
- Recent advances in the discovery and development of anti-influenza drugsExpert Opinion on Therapeutic Patents, 2002
- RNA and DNA Hydrolysis Are Catalyzed by the Influenza Virus EndonucleasePublished by Elsevier ,2000
- Metal Ion Catalysis of RNA Cleavage by the Influenza Virus EndonucleaseBiochemistry, 1999
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- THE ENZYMIC CONVERSION OF 1,2,4-TRIAZOLE-3-CARBOXAMIDE TO RIBAVIRIN-5'-PHOSPHATE AND ITS RELATIONSHIP TO THE PROPOSED MECHANISM OF ACTIONAnnals of the New York Academy of Sciences, 1977